Raphael Pharmaceutical (RAPH) Non-Current Assets (2022 - 2025)
Raphael Pharmaceutical (RAPH) posted Non-Current Assets of $2000.0 for Q4 2025, little changed sequentially from $2000.0 in Q3 2025, and little changed YoY from $2000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Non-Current Assets (2022 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Non-Current Assets for 4 years, with the latest figure at $2000.0 in Q4 2025.
- Quarterly Non-Current Assets changed 0.0% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8000.0 (down 11.11% YoY) and the FY2025 annual result came in at $2000.0, changed 0.0% from the prior year.
- Non-Current Assets was little changed at $2000.0 in Q4 2025 per RAPH's latest filing, from $2000.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $3000.0 in Q1 2024 and troughed at $1000.0 in Q1 2023.
- A 4-year average of $1857.1 and a median of $2000.0 in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets plunged 50.0% in 2023, then jumped 200.0% in 2024.
- Over 4 years, Non-Current Assets stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2000.0, $2000.0, and $2000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 2.96 Bn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |